-
1
Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis
Published 2025-01-01Subjects: Get full text
Article -
2
The optimal neoadjuvant treatment strategy for HR+/HER2 + breast cancer: a network meta-analysis
Published 2025-01-01Subjects: Get full text
Article